Please ensure Javascript is enabled for purposes of website accessibility

Surprise! Warren Buffett's Portfolio Has Marijuana Exposure

By Sean Williams - May 22, 2019 at 7:21AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Even though the Oracle of Omaha isn't feeling the buzz on cannabis, a handful of companies he owns are exposed to its growth.

Just a few weeks ago, the Oracle of Omaha, Warren Buffett, wrapped up another highly successful annual shareholder meeting for the conglomerate he's run for decades, Berkshire Hathaway (BRK.A 0.10%)(BRK.B -0.03%). This event has become something of a mecca for investing enthusiasts, allowing them to listen to what one of the most successful buy-and-hold investors in the world has to say about the stock market, the economy, and other financial matters.

But just as investors have flocked to Buffett's favorite stocks and industries for decades, they also take note when he shows skepticism toward a company, industry, or trend.

Berkshire Hathaway CEO Warren Buffett speaking with reporters at the company's annual shareholder meeting.

Berkshire Hathaway CEO Warren Buffett. Image source: The Motley Fool.

Buffett and cannabis don't mix

Despite arguably being one of the fastest growing industries, marijuana isn't exactly "high" on Buffett's buy list. To be clear, it does offer some traits that Buffett would probably appreciate, such as the likely noncyclical nature of cannabis consumption, and the fact that you don't have to dive headfirst into a grower in order to gain exposure. But when examined as a whole, there's a veritable laundry list of reasons Buffett would stay away from pot stocks rather than be a buyer.

For example, he traditionally buys into time-tested, profitable business models. The fact is that a majority of pot stocks are still losing money on an operating basis, and the industry hasn't demonstrated that it has staying power.

Another pervasive problem is that Buffett and his team generally don't want to have to babysit their holdings. He prefers to buy companies that can essentially be set in Berkshire Hathaway's portfolio and forgotten about for years. With the legal status of marijuana different in many countries and changing constantly, buying into pot stocks would require a lot of upkeep that Buffett simply isn't willing to give.

Also, don't overlook that most pot stocks are still listed on the over-the-counter (OTC) exchange, rather than a major U.S. exchange. Neither the New York Stock Exchange nor Nasdaq will allow companies that sell a federally illicit substance in the United States, such as marijuana, to list their common stock. Buffett, for his part, only cares to purchase stock in companies that are listed on major exchanges.

As I said, there's a pretty long list of reasons for Buffett to not buy marijuana stocks.

A rolled cannabis joint lying atop a cannabis leaf.

Image source: Getty Images.

But Buffett already has marijuana investment exposure!

Recently, he doubled down on his anti-cannabis rhetoric when asked by Fox Business Network anchor Liz Claman about the possibility of Coca-Cola getting into the marijuana industry. Said Buffett: "It would be a mistake for Coca-Cola to get into the marijuana-cannabis business. They have a wholesome image, and that would be detrimental to it."

Yet, what you might find surprising is that of 47 separate securities that Berkshire Hathaway owned at the end of the first quarter, at least a handful of them already have some degree of marijuana industry exposure.

As noted by my Motley Fool colleague Jason Hall, nearly $95 billion of Berkshire's $199 billion in total investments as of the end of the first quarter were in financial services companies, including big investments in Bank of America (BAC -1.71%), Wells Fargo (WFC -0.79%), and JPMorgan Chase (JPM -0.82%). As of this past weekend, Berkshire owned almost $25.5 billion worth of Bank of America stock, $18.7 billion worth of Wells Fargo stock, and $6.6 billion of JPMorgan Chase stock.

What makes these particular names stand out from the crowd is that in select U.S. states, they have been allowing marijuana businesses to set up checking and/or savings accounts, as well as gain access to basic banking services, which includes traditional loans and lines of credit.

A cannabis leaf atop a neat stack of hundred dollar bills.

Image source: Getty Images.

According to a study released in early 2017 that was commissioned by the journal American Banker, 34% of businesses that filed to operate a medical marijuana dispensary in Massachusetts between June 2015 and September 2016 had a bank account with one of the United States' big-four banks: Bank of America, Wells Fargo, JPMorgan Chase, or Citigroup, which is the only large bank Buffett's Berkshire Hathaway doesn't currently own. The study further notes that Bank of America appeared to be the most accommodating, with a little more than half of all medical cannabis applicants having an account with the bank.

This is an interesting finding given that cannabis is still a federally illicit (i.e., Schedule I) substance, and therefore most banks would be expected to avoid helping marijuana business altogether for fear of facing criminal prosecution and/or financial penalties. A banking bill working its way through Congress (the SAFE Banking Act) offers hope that new banking doors will open to the U.S. pot industry in the months and years to come.

The point here being that while the aggregate exposure in revenue dollars to the marijuana industry is likely very small, Buffett's financial-services-heavy portfolio does have at least some cannabis exposure.

Down the line, there are other avenues beyond banking that could increase Buffett's cannabis exposure. For instance, snack maker Mondelez International has talked about using cannabidiol (CBD), the nonpsychoactive cannabinoid best known for its perceived medical benefits, in its popular Chips Ahoy cookies, Cadbury chocolates, Nilla wafers, and Nutter Butter cookies. Berkshire currently holds a $30 million stake in Mondelez. 

Whether Buffett is ready or not, cannabis is liable to play a role in the performance of Berkshire Hathaway's investment portfolio.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Berkshire Hathaway Inc. Stock Quote
Berkshire Hathaway Inc.
$456,500.00 (0.10%) $468.99
Berkshire Hathaway Inc. Stock Quote
Berkshire Hathaway Inc.
$304.05 (-0.03%) $0.10
Bank of America Corporation Stock Quote
Bank of America Corporation
$33.86 (-1.71%) $0.59
JPMorgan Chase & Co. Stock Quote
JPMorgan Chase & Co.
$117.34 (-0.82%) $0.97
Wells Fargo & Company Stock Quote
Wells Fargo & Company
$41.67 (-0.79%) $0.33

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/22/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.